154 related articles for article (PubMed ID: 12661995)
1. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis.
Fehrenbach H; Zissel G; Goldmann T; Tschernig T; Vollmer E; Pabst R; Müller-Quernheim J
Eur Respir J; 2003 Mar; 21(3):421-8. PubMed ID: 12661995
[TBL] [Abstract][Full Text] [Related]
2. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis.
Pueringer RJ; Schwartz DA; Dayton CS; Gilbert SR; Hunninghake GW
Chest; 1993 Mar; 103(3):832-8. PubMed ID: 8449077
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor production by alveolar macrophages in pulmonary sarcoidosis and tuberculosis.
Foley NM; Millar AB; Meager A; Johnson NM; Rook GA
Sarcoidosis; 1992 Mar; 9(1):29-34. PubMed ID: 1344039
[TBL] [Abstract][Full Text] [Related]
4. Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis.
Zheng L; Teschler H; Guzman J; Hübner K; Striz I; Costabel U
Am J Respir Crit Care Med; 1995 Sep; 152(3):1061-6. PubMed ID: 7663784
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis.
Ishioka S; Saito T; Hiyama K; Haruta Y; Maeda A; Hozawa S; Inamizu T; Yamakido M
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Sep; 13(2):139-45. PubMed ID: 8893383
[TBL] [Abstract][Full Text] [Related]
6. Does tumour necrosis factor-alpha inhibitor infliximab induce histological resolution of pulmonary sarcoid granulomas?
Milman N; Andersen CB; Baslund B; Loft A; Iversen M
Clin Respir J; 2007 Dec; 1(2):106-13. PubMed ID: 20298289
[TBL] [Abstract][Full Text] [Related]
7. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.
Armstrong L; Foley NM; Millar AB
Thorax; 1999 Jun; 54(6):524-30. PubMed ID: 10335007
[TBL] [Abstract][Full Text] [Related]
8. Cyclic hydrostatic pressure and cotton particles stimulate synthesis by human lung macrophages of cytokines in vitro.
Lewis S; Singh D; Evans CE
Respir Res; 2009 Jun; 10(1):44. PubMed ID: 19490623
[TBL] [Abstract][Full Text] [Related]
9. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
[TBL] [Abstract][Full Text] [Related]
10. Intercellular adhesion molecule 1 (ICAM-1) in the pathogenesis of mononuclear cell alveolitis in pulmonary sarcoidosis.
Dalhoff K; Bohnet S; Braun J; Kreft B; Wiessmann KJ
Thorax; 1993 Nov; 48(11):1140-4. PubMed ID: 7905208
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bronchoalveolar lavage fluid phospholipids and cytokine release by alveolar macrophages as prognostic markers in sarcoidosis.
Tahanovich AD; Katovich IL; Baradzina HL
Respiration; 2003; 70(4):376-81. PubMed ID: 14512673
[TBL] [Abstract][Full Text] [Related]
12. Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis.
Moodley YP; Dorasamy T; Venketasamy S; Naicker V; Lalloo UG
Thorax; 2000 Aug; 55(8):696-9. PubMed ID: 10899249
[TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-alpha production in human alveolar macrophages: modulation by inhaled corticosteroid.
Marshall BG; Wangoo A; Harrison LI; Young DB; Shaw RJ
Eur Respir J; 2000 Apr; 15(4):764-70. PubMed ID: 10780771
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 in sarcoidosis.
Salez F; Gosset P; Copin MC; Lamblin Degros C; Tonnel AB; Wallaert B
Eur Respir J; 1998 Oct; 12(4):913-9. PubMed ID: 9817168
[TBL] [Abstract][Full Text] [Related]
16. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis.
Dai H; Guzman J; Chen B; Costabel U
Chest; 2005 Jan; 127(1):251-6. PubMed ID: 15653992
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14.
Striz I; Zheng L; Wang YM; Pokorná H; Bauer PC; Costabel U
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):544-7. PubMed ID: 7531099
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.
Stríz I; Wang YM; Teschler H; Sorg C; Costabel U
Lung; 1993; 171(5):293-303. PubMed ID: 7692188
[TBL] [Abstract][Full Text] [Related]
20. The value of interleukin-12 as an activity marker of pulmonary sarcoidosis.
Kim DS; Jeon YG; Shim TS; Lim CM; Lee SD; Koh Y; Kim WS; Kim WD
Sarcoidosis Vasc Diffuse Lung Dis; 2000 Oct; 17(3):271-6. PubMed ID: 11033843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
